Pfizer and BioNTech announce vaccine candidate against COVID-19 achieved success in first interim analysis from Phase 3 study.
Lipid nanoparticles boost potential vaccine against SARS-CoV-2
Researchers enhance the immune response against the receptor binding domain of SARS-CoV-2 by presenting it on liposomes, providing a promising strategy for vaccine development targeting this domain.
A novel vaccine additive shows good safety profile
A new vaccine adjuvant, which helps stimulate the immune system, has been developed based on two chemicals that are produced by the body.
A step toward a universal flu vaccine
With computer models and lab experiments, researchers are working on a strategy for vaccines that could protect against any influenza virus.
Moderna’s COVID-19 vaccine shows immune response in elderly patients
A small trial indicates that Moderna’s experimental SARS-CoV-2 vaccine is effective and safe in older adults, a population group most vulnerable to severe COVID-19.
Can the pneumonia vaccine protect against COVID-19?
Where pneumococcal vaccination rates are high, COVID-19 cases are low and vice-versa.
AstraZeneca COVID-19 vaccine trial put on hold
The global trial run by researchers at Oxford and AstraZeneca has been paused due to an adverse reaction at a UK site. Whether the reaction is related to the vaccine is still unknown.
Nasal vaccine against SARS-CoV-2 prevents infection and spread throughout the body
Study claims nasal delivery protects first site of infection and produces widespread immune response compared to intramuscular injection.
Two coronavirus vaccines show immune response in human trials
Scientists express cautious optimism about two potential COVID-19 vaccine candidates from the UK and China.
Challenges in vaccine development during an evolving pandemic
As researchers race to produce the long-awaited SARS-CoV-2 vaccine, the global scale of this pandemic is posing some unique hurdles.